IPG Photonics (NASDAQ:IPGP) Posts Q2 Revenue of $279M, Adjusted EPS Beats by 49%

IPG Photonics Corporation (NASDAQ: IPGP) reported Q2 2026 revenue of $278.6 million, up 11.1% year over year, marking its third consecutive quarter of double-digit revenue growth. Adjusted EPS of $0.58 exceeded the $0.39 consensus estimate by 49%, while GAAP gross margin expanded 310 basis points to 40.4%. Shares gained 7.88% on Tuesday, August 4, while the S&P 500 rose 1.80%.

Q2 2026 Results

• Revenue: $278.6 million, up 11.1% from $250.7 million in Q2 2025, with Industrial Solutions growing 16% year over year to $237.0 million and accounting for 85% of total revenue.
• Adjusted EPS: $0.58, up 93.3% from $0.30 in Q2 2025, beating the $0.39 consensus estimate by 49%.
• GAAP operating income: $4.5 million, compared to $0.1 million in the prior-year period, on a GAAP operating margin of 1.6%.
• Adjusted EBITDA: $48.5 million, up 54% from $31.5 million in Q2 2025.
• Cash flow: $37.8 million from operations; capital expenditures of $20.7 million, yielding free cash flow of $17.1 million.

What Drove the Results

Adjusted EPS of $0.58 beat the $0.39 consensus by $0.19. Revenue of $278.6 million came in above the midpoint of the company's own guidance range, though no specific consensus revenue estimate was available for direct comparison. The GAAP net income figure of $5.2 million fell 21.2% from $6.6 million in Q2 2025, a meaningful divergence from the adjusted figures, reflecting the impact of non-GAAP adjustments including items not individually disclosed in the summary data.

Gross margin expansion was a central feature of the quarter. GAAP gross margin of 40.4% and adjusted gross margin of 40.7% both improved materially year over year, driven by lower product costs, reduced inventory provisions, and $4.7 million in tariff refunds recorded in the period. Emerging growth products reached 58% of total revenue, up from 53% in the prior quarter. By geography, Asia sales grew 19% and Europe grew 5% year over year, while North America declined 2%.

Advanced Solutions revenue decreased 9% year over year to $41.5 million, a drag offset partially by growth in semiconductor applications. The company also announced an acquisition of Lumibird Medical, a move it described as accelerating its strategic expansion into medical markets within the Advanced Solutions segment.

Q3 2026 Guidance

For Q3 2026, IPG Photonics guided for revenue of $265 million to $295 million, adjusted gross margin of 37.5% to 40.5%, adjusted operating expenses of $92 million to $95 million, adjusted EPS of $0.30 to $0.60, and adjusted EBITDA of $35 million to $51 million. The company noted that book-to-bill remained above 1.0 in Q2, indicating demand for its products exceeded shipments in the period.

Wall Street View

Analyst sentiment heading into the print leaned constructive, with the most recent consensus as of August 1, 2026 showing 12 Buy or Strong Buy ratings against 4 Holds and 1 Sell. No specific price target revisions were available in the source data as of this report.

Investor Takeaway

The Q2 print shows a company where adjusted profitability is recovering at a faster pace than GAAP figures suggest: adjusted EBITDA of $48.5 million was 54% above the year-ago level even as GAAP net income fell 21.2%, a gap investors will need to monitor as the Lumibird Medical acquisition closes and integrates. The Q3 adjusted EPS guidance midpoint of $0.45 implies a sequential step-down from Q2's $0.58, which, combined with the slightly wider revenue guidance range and explicit tariff policy uncertainty flagged by management, introduces variability that the market will need to price through the second half of 2026.